FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108149257> ?p ?o ?g. }

• W2108149257 endingPage "2467" @default.
• W2108149257 startingPage "2459" @default.
• W2108149257 abstract "AbstractTumour hypoxia is a negative factor in cancer radiotherapy. In order to overcome the problem, various pharmacotherapies have been investigated as an adjunct to radiotherapy. The use of hypoxic cell sensitisers is a classical strategy, and many new compounds have been developed and investigated. Development of more efficient compounds than those currently available seems difficult and clinical studies to prove the efficacy of the existing compounds are encouraged, especially in combination with radiosurgery, intraoperative radiotherapy, and interstitial irradiation, in which a single high dose of radiation is used. Following the advent of hypoxic cell sensitisers, hypoxic cytotoxins have become available. Among them, tirapazamine has already gained success when combined with cisplatin in non-small cell lung cancer. The beneficial effect of tirapazamine when combined with radiation needs to be determined. As a third-generation compound in this field, antitumour prodrugs that are activated by irradiation under hypoxic conditions via one-electron reduction have been proposed. Prodrugs of 5-fluorouracil and 5-fluoro-2’-deoxyuridine have shown in vivo as well as in vitro activity. Although clinical evaluation of the compounds is not warranted due to a relatively low in vivo effect, this strategy appears promising if the prodrug design can be applied to more potent agents that shall be developed in future.Keywordsbioreductive agentdoranidazolehypoxic cell sensitiserKU-2285radiation-activated prodrugtirapazamine" @default.
• W2108149257 created "2016-06-24" @default.
• W2108149257 creator A5020793018 @default.
• W2108149257 creator A5059868927 @default.
• W2108149257 creator A5064384297 @default.
• W2108149257 creator A5071240286 @default.
• W2108149257 date "2004-12-01" @default.
• W2108149257 modified "2023-09-25" @default.
• W2108149257 title "The Japanese experiences with hypoxia-targeting pharmacoradiotherapy: from hypoxic cell sensitisers to radiation-activated prodrugs" @default.
• W2108149257 cites W1499177907 @default.
• W2108149257 cites W1868704956 @default.
• W2108149257 cites W1874135117 @default.
• W2108149257 cites W1970180186 @default.
• W2108149257 cites W1977660331 @default.
• W2108149257 cites W1983782827 @default.
• W2108149257 cites W1984435803 @default.
• W2108149257 cites W1985049521 @default.
• W2108149257 cites W1985716302 @default.
• W2108149257 cites W1988508361 @default.
• W2108149257 cites W1994555849 @default.
• W2108149257 cites W1996519451 @default.
• W2108149257 cites W2002253169 @default.
• W2108149257 cites W2017742180 @default.
• W2108149257 cites W2032093753 @default.
• W2108149257 cites W2032269386 @default.
• W2108149257 cites W2034798313 @default.
• W2108149257 cites W2046492464 @default.
• W2108149257 cites W2048544046 @default.
• W2108149257 cites W2053951681 @default.
• W2108149257 cites W2056351612 @default.
• W2108149257 cites W2064902793 @default.
• W2108149257 cites W2066082960 @default.
• W2108149257 cites W2066097953 @default.
• W2108149257 cites W2068555276 @default.
• W2108149257 cites W2080141853 @default.
• W2108149257 cites W2085312856 @default.
• W2108149257 cites W2087604644 @default.
• W2108149257 cites W2093596753 @default.
• W2108149257 cites W2093716126 @default.
• W2108149257 cites W2093988815 @default.
• W2108149257 cites W2102910049 @default.
• W2108149257 cites W2117064395 @default.
• W2108149257 cites W2131194912 @default.
• W2108149257 cites W2136817236 @default.
• W2108149257 cites W2155258039 @default.
• W2108149257 cites W2163801438 @default.
• W2108149257 cites W2166828354 @default.
• W2108149257 cites W2171858259 @default.
• W2108149257 doi "https://doi.org/10.1517/14656566.5.12.2459" @default.
• W2108149257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15571464" @default.
• W2108149257 hasPublicationYear "2004" @default.
• W2108149257 type Work @default.
• W2108149257 sameAs 2108149257 @default.
• W2108149257 citedByCount "13" @default.
• W2108149257 countsByYear W21081492572015 @default.
• W2108149257 countsByYear W21081492572018 @default.
• W2108149257 countsByYear W21081492572020 @default.
• W2108149257 countsByYear W21081492572021 @default.
• W2108149257 crossrefType "journal-article" @default.
• W2108149257 hasAuthorship W2108149257A5020793018 @default.
• W2108149257 hasAuthorship W2108149257A5059868927 @default.
• W2108149257 hasAuthorship W2108149257A5064384297 @default.
• W2108149257 hasAuthorship W2108149257A5071240286 @default.
• W2108149257 hasConcept C108215921 @default.
• W2108149257 hasConcept C109316439 @default.
• W2108149257 hasConcept C126322002 @default.
• W2108149257 hasConcept C150903083 @default.
• W2108149257 hasConcept C178790620 @default.
• W2108149257 hasConcept C185592680 @default.
• W2108149257 hasConcept C202751555 @default.
• W2108149257 hasConcept C207001950 @default.
• W2108149257 hasConcept C2776313096 @default.
• W2108149257 hasConcept C2779081379 @default.
• W2108149257 hasConcept C502942594 @default.
• W2108149257 hasConcept C509974204 @default.
• W2108149257 hasConcept C540031477 @default.
• W2108149257 hasConcept C55493867 @default.
• W2108149257 hasConcept C71924100 @default.
• W2108149257 hasConcept C7836513 @default.
• W2108149257 hasConcept C86803240 @default.
• W2108149257 hasConcept C98274493 @default.
• W2108149257 hasConceptScore W2108149257C108215921 @default.
• W2108149257 hasConceptScore W2108149257C109316439 @default.
• W2108149257 hasConceptScore W2108149257C126322002 @default.
• W2108149257 hasConceptScore W2108149257C150903083 @default.
• W2108149257 hasConceptScore W2108149257C178790620 @default.
• W2108149257 hasConceptScore W2108149257C185592680 @default.
• W2108149257 hasConceptScore W2108149257C202751555 @default.
• W2108149257 hasConceptScore W2108149257C207001950 @default.
• W2108149257 hasConceptScore W2108149257C2776313096 @default.
• W2108149257 hasConceptScore W2108149257C2779081379 @default.
• W2108149257 hasConceptScore W2108149257C502942594 @default.
• W2108149257 hasConceptScore W2108149257C509974204 @default.
• W2108149257 hasConceptScore W2108149257C540031477 @default.
• W2108149257 hasConceptScore W2108149257C55493867 @default.
• W2108149257 hasConceptScore W2108149257C71924100 @default.
• W2108149257 hasConceptScore W2108149257C7836513 @default.
• W2108149257 hasConceptScore W2108149257C86803240 @default.

• next